Top for 24 hours
FDA Warns on Hepatitis C Drugs
The Food and Drug Administration is warning about the risk of reactivation of hepatitis B among patients who have had that disease and who are taking some prominent and expensive newer medicines for hepatitis C.
|Related: "FDA Warns on Hepatitis C Drugs" ↓|
|Last News ↓|